| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |